Page last updated: 2024-09-05

sorafenib and 7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine

sorafenib has been researched along with 7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine)
Trials
(7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine)
Recent Studies (post-2010) (7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine)
6,5207305,251903

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine (IC50)
Glycogen synthase kinase-3 beta Sus scrofa (pig)0.65
[Tau protein] kinase Sus scrofa (pig)0.65
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.15
G1/S-specific cyclin-E2Homo sapiens (human)0.4
Cyclin-dependent kinase 1Saccharomyces cerevisiae S288C2.5
Cyclin-dependent kinase 1Homo sapiens (human)0.15
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.15
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.3333
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.3333
Cyclin-A2Homo sapiens (human)0.12
G1/S-specific cyclin-E1Homo sapiens (human)0.4
Cyclin-dependent kinase 2Homo sapiens (human)0.26
Mitogen-activated protein kinase 8Homo sapiens (human)3.3
Mitogen-activated protein kinase 9Homo sapiens (human)3.3
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.8239
Glycogen synthase kinase-3 betaHomo sapiens (human)0.9326
Mitogen-activated protein kinase 10Homo sapiens (human)3.3
Cyclin-A1Homo sapiens (human)0.12
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.245
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.245
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.15
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.3333

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, W; Kan, Q; Li, Y; Tian, X; Wang, S; Wei, H; Yang, Z1

Reviews

1 review(s) available for sorafenib and 7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine

ArticleYear
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Animals; Crystallography, X-Ray; Cyclin-Dependent Kinases; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors

2019